相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preclinical models of non-alcoholic fatty liver disease
Prasanna K. Santhekadur et al.
JOURNAL OF HEPATOLOGY (2018)
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
Jinsheng Yu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements
Pratiksha I. Thakore et al.
NATURE METHODS (2015)
Inhibition of MicroRNA-24 Expression in Liver Prevents Hepatic Lipid Accumulation and Hyperlipidemia
Raymond Ng et al.
HEPATOLOGY (2014)
Therapeutic targeting of microRNAs: current status and future challenges
Zhonghan Li et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
MicroRNAs as Mediators in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Steatohepatitis
PP Becker et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2014)
Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling
Wei Liu et al.
NATURE COMMUNICATIONS (2014)
Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis
Elena Bellafante et al.
HEPATOLOGY (2013)
In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
Giridhar Kanuri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice
Jiansheng Huang et al.
FASEB JOURNAL (2012)
Liver-Specific PGC-1beta Deficiency Leads to Impaired Mitochondrial Function and Lipogenic Response to Fasting-Refeeding
Kari T. Chambers et al.
PLOS ONE (2012)
Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378☆
Michele Carrer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Optimized Adeno-Associated Virus (AAV)-Protein Phosphatase-5 Helper Viruses for Efficient Liver Transduction by Single-Stranded AAV Vectors: Therapeutic Expression of Factor IX at Reduced Vector Doses
Giridhara R. Jayandharan et al.
HUMAN GENE THERAPY (2010)
Liver X receptor in cholesterol metabolism
Chunyan Zhao et al.
JOURNAL OF ENDOCRINOLOGY (2010)
PGC-1β-Regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERRα
Di Shao et al.
MITOCHONDRION (2010)
Biogenesis of small RNAs in animals
V. Narry Kim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin
Robert Domitrovic et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
Onpan Cheung et al.
HEPATOLOGY (2008)
Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet
Mary E. Rinella et al.
JOURNAL OF LIPID RESEARCH (2008)
Dissection of the insulin-sensitizing effect of liver X receptor ligands
S. Renee Commerford et al.
MOLECULAR ENDOCRINOLOGY (2007)
Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2diphenylethyl)amino]propyloxy] phenylacetic acid hydrochloride (GW3965)
Pia Kotokorpi et al.
MOLECULAR PHARMACOLOGY (2007)
Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity -: Potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation
Sarah Crunkhorn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis
Junichiro Sonoda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A human hepatocellular in vitro model to investigate steatosis
Maria Jose Gomez-Lechon et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
The physiology of obese-hyperglycemic mice [ob/ob mice]
Per Lindstrom
THESCIENTIFICWORLDJOURNAL (2007)
Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance
Claudia R. Vianna et al.
CELL METABOLISM (2006)
Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance
Christopher J. Lelliott et al.
PLOS BIOLOGY (2006)
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
BN Finck et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Coactivation of Foxa2 through Pgc-1β promotes liver fatty acid oxidation and triglyceride/VLDL secretion
C Wolfrum et al.
CELL METABOLISM (2006)
Matlnspector and beyond: promoter analysis based on transcription factor binding sites
K Cartharius et al.
BIOINFORMATICS (2005)
Metabolic control through the PGC-1 family of transcription coactivators
JD Lin et al.
CELL METABOLISM (2005)
MicroRNA biogenesis: Coordinated cropping and dicing
VN Kim
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
LXRs regulate the balance between fat storage and oxidation
NY Kalaany et al.
CELL METABOLISM (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Obesity and hepatocellular carcinoma
SH Caldwell et al.
GASTROENTEROLOGY (2004)
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans
ZQ Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator-activated receptor α (PPARα)
MJ Holness et al.
BIOCHEMICAL JOURNAL (2002)
分享论文
